VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HQY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HQYHealthEquity, Inc.
$88.46$7.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHQYBalance Sheet

HealthEquity, Inc. (HQY) Balance Sheet

14Y historyFree accessUpdated daily

The company maintains a stable capital structure with a debt-to-equity ratio of 0.48 as of 2027Q1, supported by a robust liquidity position evidenced by a current ratio of 3.44.

HQY Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Jan'25Jan'24Jan'23Jan'22Jan'21Jan'20Jan'19Jan'18Jan'17Jan'16Jan'15Jan'14Jan'13
Total Current Assets466.53M512.28M477.75M557.44M382.89M351.34M460.18M297.3M394.68M265.4M200.82M143.05M124.72M23.76M15.33M
Cash & Short-Term Investments265.37M318.93M295.95M403.98M254.27M225.41M328.8M191.73M361.48M240.27M180.36M123.78M111M13.92M5.91M
Cash Only265.37M318.93M295.95M403.98M254.27M225.41M328.8M191.73M361.48M199.47M139.95M83.64M111M13.92M5.91M
Short-Term Investments00000000040.8M40.41M40.13M000
Accounts Receivable122M123.7M118.01M104.89M96.83M87.43M72.77M70.86M25.67M21.6M17M14.31M9.05M5.71M4.15M
Days Sales Outstanding31.9434.3735.938.341.0242.1836.2148.6232.6234.3534.7941.1937.6233.5832.88
Inventory000000000215K592K620K625K391K272K
Days Inventory Outstanding---------0.792.834.015.494.634.21
Other Current Assets79.16M69.66M63.8M48.56M31.79M38.49M58.61M34.71M7.53M3.31M2.87M4.34M1.76M3.08M5M
Total Non-Current Assets2.84B2.92B2.97B2.61B2.71B2.76B2.25B2.27B115.34M103.76M78.32M76.75M34.05M31.33M30.16M
Property, Plant & Equipment38.38M39.49M46.42M54.39M69.32M86.98M118.61M116.66M8.22M7.84M5.17M3.51M2.58M1.99M1.13M
Fixed Asset Turnover32.99x33.26x25.84x18.38x12.43x8.70x6.18x4.56x34.93x29.29x34.50x36.16x34.09x31.13x40.64x
Goodwill1.65B1.65B1.65B1.65B1.65B1.65B1.33B1.33B4.65M4.65M4.65M4.65M4.65M4.65M4.65M
Intangible Assets1.07B1.1B1.2B835.95M936.36M973.14M767M783.28M79.67M83.64M65.02M66.84M26.54M24.69M24.38M
Long-Term Investments12.16M3.29M0000000706K760K-2.64M281K00
Other Non-Current Assets80.09M131.67M71.57M67.87M52.18M49.81M37.42M35.09M21.12M1.47M1.1M1.75M-1.76M0-30.16M
Total Assets3.31B3.43B3.45B3.16B3.09B3.11B2.71B2.56B510.02M369.16M279.14M219.79M158.77M55.09M46.3M
Asset Turnover0.39x0.38x0.35x0.32x0.28x0.24x0.27x0.21x0.56x0.62x0.64x0.58x0.55x1.13x1.00x
Asset Growth %-9.07%-0.48%9%2.42%-0.59%14.64%5.67%402.92%38.16%32.25%27%38.44%188.2%18.98%-
Total Current Liabilities135.74M156.85M156.32M117.09M131.06M153.19M204.7M151.94M29.05M20.49M15.7M12.11M8.83M9.43M8.3M
Accounts Payable14.22M12.16M14.36M12.04M13.9M27.54M1.61M3.98M3.52M2.42M3.22M2.43M1.3M2.37M876K
Days Payables Outstanding13.8811.0910.339.3610.8824.191.496.0311.478.8815.4115.7311.4528.0213.55
Short-Term Debt09.91M0017.5M8.75M62.5M39.06M0000000
Deferred Revenue (Current)000000000000000
Other Current Liabilities26.66M134.78M69.33M49.61M45.84M47.14M50.67M50.12M16.98M12.55M8.72M7.78M5.3M4.13M4.55M
Current Ratio3.44x3.27x3.06x4.76x2.92x2.29x2.25x1.96x13.58x12.95x12.79x11.82x14.12x2.52x1.85x
Quick Ratio3.44x3.27x3.06x4.76x2.92x2.29x2.25x1.96x13.58x12.94x12.75x11.77x14.05x2.48x1.81x
Cash Conversion Cycle18.07--------26.2622.2129.4731.6610.1923.54
Total Non-Current Liabilities1.12B1.17B1.18B1.01B1.06B1.1B1.13B1.38B3.88M2.4M1.49M4.23M5.84M11.65M0
Long-Term Debt942.66M957.38M1.06B874.97M907.84M922.08M924.22M1.18B0000000
Capital Lease Obligations140.77M34.19M42.22M48.77M58.99M65.23M74.22M68.02M0000000
Deferred Tax Liabilities428.96M145.42M55.83M68.67M82.67M99.85M119.73M130.49M916K037K4M5.36M5.08M0
Other Non-Current Liabilities52.93M31.01M22.96M19.27M12.71M14.19M8.81M2.63M2.97M2.4M1.46M236K488K6.58M0
Total Liabilities1.26B1.32B1.33B1.13B1.19B1.25B1.33B1.53B32.94M22.89M17.2M16.34M14.67M21.08M8.3M
Total Debt984.68M1B1.11B933.14M994.49M1.01B1.07B1.3B0000000
Net Debt719.31M682.55M812.57M529.16M740.22M782.82M746.17M1.11B-361.48M-199.47M-139.95M-83.64M-111M-13.92M-5.91M
Debt / Equity0.48x0.48x0.52x0.46x0.52x0.54x0.78x1.26x-------
Debt / EBITDA3.13x3.11x2.82x3.32x5.00x5.67x5.49x7.91x-------
Net Debt / EBITDA2.28x2.12x2.07x1.88x3.72x4.40x3.81x6.75x-3.77x-2.83x-2.57x-2.41x-6.00x-0.88x-0.56x
Interest Coverage6.01x5.64x2.89x2.33x0.21x-0.94x1.12x2.74x-191.47x---123.14x20.94x
Total Equity2.05B2.11B2.11B2.04B1.9B1.85B1.38B1.03B477.08M346.27M261.94M203.46M144.09M34.01M35.6M
Equity Growth %-4.02%-0.36%3.93%7.35%2.32%34.37%33.82%115.96%37.77%32.2%28.74%41.2%323.71%-4.49%-
Book Value per Share24.0924.0923.8123.4022.4522.2818.2215.057.535.604.373.462.780.750.78
Total Shareholders' Equity2.05B2.11B2.11B2.04B1.9B1.85B1.38B1.03B477.08M346.27M261.94M203.46M144.09M34.01M35.6M
Common Stock8K8K9K9K8K8K8K7K6K6K6K6K5K1K1K
Retained Earnings177.2M195.91M209.27M205.63M149.92M176.06M220.35M211.51M171.85M85.3M29.98M3.61M-13M-23.17M-19.07M
Treasury Stock000000000000000
Accumulated OCI-31.75M-5.71M0000000-269K-165K-98K000
Minority Interest000000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Interest rate sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Stable Capital Base Amid Maturation

According to recent financial statements, HealthEquity has maintained a consistent total asset base of approximately $3.3B to $3.5B over the last ten quarters, suggesting that the company is transitioning from an aggressive acquisition-led growth phase toward a more stable, organic capital structure.

The stability in total assets despite ongoing portfolio acquisitions indicates that the company is effectively integrating new assets while managing its existing balance sheet footprint. This trajectory suggests that management is prioritizing the optimization of existing custodial relationships over rapid, debt-fueled expansion.

Leverage Managed Through Strategic Debt

Based on reported figures, the company maintains a debt-to-equity ratio of 0.48 as of 2027Q1, reflecting a disciplined approach to leverage that has remained relatively flat despite the periodic financing of large-scale custodial portfolio acquisitions over the past two years.

The consistent D/E ratio suggests that management utilizes debt strategically to fund inorganic growth while ensuring that leverage does not become a structural burden. Investors should monitor whether this debt level remains sustainable if interest rate volatility impacts the yield on the custodial assets used to service these obligations.

Goodwill Dominance in Asset Mix

As disclosed in recent SEC filings, goodwill remains a significant component of the balance sheet at $1.6B, representing nearly half of total assets, which underscores the company's reliance on past acquisitions to build its current market position and proprietary technology platform.

The high concentration of goodwill warrants ongoing scrutiny regarding potential impairment risks, particularly if the integration of acquired portfolios fails to yield the expected synergies. The minimal net PPE of $38.4M confirms an asset-light business model that relies primarily on intangible value and platform scalability.

Robust Liquidity Buffers Maintained

As reported in quarterly filings, the current ratio has fluctuated between 3.06 and 4.76 over the last ten quarters, indicating a strong liquidity position that provides a substantial buffer against operational shocks or sudden changes in member spending patterns.

This high current ratio suggests that the company maintains ample short-term assets to cover its liabilities, which is critical given the lumpy nature of interchange revenue and custodial cash flows. The liquidity profile appears well-positioned to support ongoing operational needs without requiring immediate external financing.

Retained Earnings Driving Equity Quality

Analysis of the balance sheet shows that equity has remained resilient at $2.0B as of 2027Q1, supported by a steady accumulation of retained earnings that reflects the company's ability to generate consistent profitability despite the costs associated with its aggressive M&A strategy.

The growth in retained earnings suggests that the core business model is fundamentally sound and capable of self-funding its operations. However, the impact of stock-based compensation on equity dilution remains a factor that investors should track to ensure that shareholder value is not being eroded over time.

HQY — Frequently Asked Questions

Quick answers to the most common questions about buying HQY stock.

What are the total assets of HealthEquity, Inc. (HQY)?

As of 2026, HealthEquity, Inc. (HQY) had total assets of $3.43B including $512.3M in current assets.

How much debt does HealthEquity, Inc. (HQY) have?

HealthEquity, Inc. (HQY) carries total debt of $1.00B, offset by $318.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of HealthEquity, Inc.?

HealthEquity, Inc. (HQY) has total shareholders' equity (book value) of $2.11B ($24.09 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is HealthEquity, Inc.'s current ratio and liquidity?

HealthEquity, Inc. (HQY) reported a current ratio of 3.27x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.